ProCE Banner Activity

Mechanism of Action and Clinical Rationale for Immunotherapy in Bladder Cancer

Slideset Download
In this downloadable slideset, Elizabeth R. Plimack, MD, MS, discusses the mechanism of action and clinical rationale for the use of immune checkpoint inhibitors in patients with bladder cancer.

Released: February 12, 2018

Expiration: February 11, 2019

No longer available for credit.

Share

Supporters

Astellas Text

Merck Oncology

Seagen

Partners

BCAN

ProCE Banner